Cipla Ltd.
BSE: 500087 | NSE: CIPLA
Large Cap | Pharmaceuticals & Drugs
1426.80
-11.95 (-0.83%) Cipla - Quaterly Results
Date: 29-07-2022
The sales declined to Rs. 31571.30 millions for the June 2022 quarter as compared to Rs. 35106.70 millions during the corresponding quarter last year.The Company's Net profit for the June 2022 quarter have declined marginally to Rs. 6440.00 millions as against Rs. 7885.10 millions reported during the corresponding quarter ended.Operating profit for the quarter ended June 2022 decreased to 9750.60 millions as compared to 11977.80 millions of corresponding quarter ended June 2021.
(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202206 | 202106 | % Var | 202206 | 202106 | % Var | 202203 | 202103 | % Var | |
| Sales | 31571.30 | 35106.70 | -10.07 | 31571.30 | 35106.70 | -10.07 | 130917.90 | 113027.10 | 15.83 |
| Other Income | 1176.80 | 796.60 | 47.73 | 1176.80 | 796.60 | 47.73 | 6667.00 | 2302.80 | 189.52 |
| PBIDT | 9750.60 | 11977.80 | -18.59 | 9750.60 | 11977.80 | -18.59 | 40331.70 | 32976.90 | 22.30 |
| Interest | 22.10 | 80.00 | -72.38 | 22.10 | 80.00 | -72.38 | 269.30 | 450.70 | -40.25 |
| PBDT | 9728.50 | 11897.80 | -18.23 | 9728.50 | 11897.80 | -18.23 | 40062.40 | 32526.20 | 23.17 |
| Depreciation | 1074.60 | 1139.70 | -5.71 | 1074.60 | 1139.70 | -5.71 | 4600.10 | 4686.20 | -1.84 |
| PBT | 8653.90 | 10758.10 | -19.56 | 8653.90 | 10758.10 | -19.56 | 35462.30 | 27840.00 | 27.38 |
| TAX | 2213.90 | 2873.00 | -22.94 | 2213.90 | 2873.00 | -22.94 | 8568.40 | 7393.50 | 15.89 |
| Deferred Tax | -112.50 | -89.30 | 25.98 | -112.50 | -89.30 | 25.98 | -304.00 | -169.20 | 79.67 |
| PAT | 6440.00 | 7885.10 | -18.33 | 6440.00 | 7885.10 | -18.33 | 26893.90 | 20446.50 | 31.53 |
| Equity | 1613.80 | 1613.20 | 0.04 | 1613.80 | 1613.20 | 0.04 | 1613.60 | 1612.90 | 0.04 |
| PBIDTM(%) | 30.88 | 34.12 | -9.48 | 30.88 | 34.12 | -9.48 | 30.81 | 29.18 | 5.59 |